Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells

Activation of the Her2 (ErbB2) oncogene is implicated in the development of breast, ovary and other cancers. Here, we show that expression of NeuT, a mutant‐activated rodent isoform of Her2, in immortalized breast epithelial cells, while promoting senescence‐associated morphological changes, up‐regulation of senescence‐associated β‐galactosidase activity, and accumulation of the cyclin‐dependent kinase inhibitor p21, failed to trigger the major senescence end‐point, i.e. permanent growth arrest. Similar senescence‐associated phenotype with incomplete growth arrest, which we dubbed senescence with incomplete growth arrest (SWING), could also be triggered by the expression of the Ras oncogene. SWING phenotype was stable, and persisted in tumor xenografts established from NeuT‐transduced cells. Furthermore, a significant population of cells in SWING state was found in tumors in the MMTV/NeuT transgenic mouse model. SWING cells showed downregulation of histone H2AX, critical for repair of double‐stranded DNA breaks, and impaired activation of Chk1 kinase. Overall, SWING cells were characterized by increased DNA instability and hypersensitivity to genotoxic stresses. We propose that the SWING state could be a stage in the process of cancer development.

[1]  M. Jackson,et al.  TGF-β signaling engages an ATM-CHK2-p53–independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells , 2011, Proceedings of the National Academy of Sciences.

[2]  J. Campisi.  Cellular senescence: putting the paradoxes in perspective. , 2011, Current opinion in genetics & development.

[3]  S. Turner,et al.  Jailbreak: oncogene-induced senescence and its evasion. , 2011, Cellular signalling.

[4]  M. Sherman,et al.  HSP72 depletion suppresses γH2AX activation by genotoxic stresses via p53/p21 signaling , 2010, Oncogene.

[5]  L. Donehower,et al.  Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation , 2010, Proceedings of the National Academy of Sciences.

[6]  S. Devries,et al.  Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast , 2009, The American journal of surgical pathology.

[7]  Heidi S Feiler,et al.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. , 2009, Cancer research.

[8]  K. Miyagawa,et al.  The ATR-Chk1 pathway plays a role in the generation of centrosome aberrations induced by Rad51C dysfunction , 2009, Nucleic acids research.

[9]  C. Bassing,et al.  ATR and H2AX Cooperate in Maintaining Genome Stability under Replication Stress* , 2009, Journal of Biological Chemistry.

[10]  T. Waldman,et al.  Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells , 2008, Molecular and Cellular Biology.

[11]  F. Alt,et al.  Complementary functions of ATM and H2AX in development and suppression of genomic instability , 2008, Proceedings of the National Academy of Sciences.

[12]  M. Sherman,et al.  Triggering senescence programs suppresses Chk1 kinase and sensitizes cells to genotoxic stresses. , 2008, Cancer research.

[13]  Atsushi Miyawaki,et al.  Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.

[14]  M. Malumbres,et al.  Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression , 2007, Oncogene.

[15]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[16]  Lewis A. Chodosh,et al.  Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis , 2007, Nature Cell Biology.

[17]  M. Sherman,et al.  High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. , 2007, Cancer research.

[18]  P. Yaswen,et al.  Oncogene-Induced Senescence Pathways Weave an Intricate Tapestry , 2007, Cell.

[19]  Frédérick A. Mallette,et al.  The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. , 2007, Genes & development.

[20]  Aaron Bensimon,et al.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.

[21]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[22]  P. Minoo,et al.  Senescence and serration: a new twist to an old tale , 2006, The Journal of pathology.

[23]  A. Weeraratna,et al.  Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells , 2006, Oncogene.

[24]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[25]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[26]  H. Stein,et al.  Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.

[27]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[28]  J. Hayes,et al.  Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. , 2005, Molecular cell.

[29]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[30]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[31]  K. Helin,et al.  Deregulated E2F Activity Induces Hyperplasia and Senescence-Like Features in the Mouse Pituitary Gland , 2005, Molecular and Cellular Biology.

[32]  Jan G Hengstler,et al.  Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. , 2005, Cancer research.

[33]  D. Mittelman,et al.  DNA end joining becomes less efficient and more error-prone during cellular senescence. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Lowe,et al.  Executing Cell Senescence , 2004, Cell cycle.

[35]  P. Yaswen,et al.  Human epithelial cell immortalization as a step in carcinogenesis. , 2003, Cancer letters.

[36]  P. Meltzer,et al.  High frequency of BRAF mutations in nevi , 2003, Nature Genetics.

[37]  Soyoung Lee,et al.  A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy , 2002, Cell.

[38]  P. Yaswen,et al.  Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion , 2002, Oncogene.

[39]  P. Yaswen,et al.  Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor β growth inhibition in p16INK4A(−) human mammary epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Lowe,et al.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.

[41]  D. Woods,et al.  Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.

[42]  A. Brenner,et al.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.

[43]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[44]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[45]  F. Ciardiello,et al.  Invasive phenotype of MCF10A cells overexpressing c‐Ha‐ras and c‐erbB‐2 oncogenes , 1995, International journal of cancer.

[46]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[47]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[48]  P. Leder,et al.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.

[49]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[50]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.